SAVIMS

SAVIMS logo white
Menu

Vaccines

Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Ethical and Scientific Considerations for Mpox Vaccination Programs in Africa

| | Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Edeling, H. (2024). Ethical and scientific considerations for Mpox vaccination programs in Africa. SAVIMS. Summary: The article by Dr. Herman Edeling discusses critical ethical and scientific considerations surrounding Mpox vaccination programmes in Africa. It highlights the need for comprehensive clinical assessments and accurate differential diagnoses for blistering skin disorders, emphasising the limitations of current […]

Epidemiological surveillance, Monkeypox, Other scientific evidence, Resource Type, Statistical evidence, Treatment, Vaccines, Viral illnesses

Understanding Mpox: A Comprehensive Overview

| | Epidemiological surveillance, Monkeypox, Other scientific evidence, Resource Type, Statistical evidence, Treatment, Vaccines, Viral illnesses

Reference: World Health Organization. (2024). Mpox. Retrieved from https://www.who.int/news-room/fact-sheets/detail/mpox Summary: Mpox, formerly known as monkeypox, is a viral infection caused by the monkeypox virus, belonging to the Orthopoxvirus genus. The disease presents with symptoms such as fever, rash, headache, muscle pain, and swollen lymph nodes, lasting typically 2–4 weeks. Transmission occurs via close contact with

Covid-19 vaccines, Monkeypox, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

The Truth Behind Monkey-Pox: A Potential COVID Vaccine Side-Effect

| | Covid-19 vaccines, Monkeypox, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Turner, H. (2024, August 23). Virologists blow the whistle: MPOX is actually known side-effect of COVID vax! Hal Turner Radio Show. https://halturnerradioshow.com/index.php/news-selections/world-news/virologists-blow-the-whistle-mpox-is-actually-known-side-effect-of-covid-vax Summary: In a controversial assertion, top virologists, including Dr. Poornima Wagh, have challenged the World Health Organization’s (WHO) narrative surrounding the monkey-pox outbreak. They claim that the symptoms attributed to monkey-pox are

Genetic vaccines, Monkeypox, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

South African Group Challenges WHO’s Monkeypox Emergency Declaration

| | Genetic vaccines, Monkeypox, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Wilson, R. (2024, August 22). South African group refutes WHO’s declaration of mpox emergency and warns the public about the risks of the vaccine. The Exposé. Retrieved from https://expose-news.com/2024/08/22/south-african-group-refutes-whos-declaration Summary: The South Africa Vaccine Injury Medico-Legal Study Group (SAVIMS) publicly contested the World Health Organisation’s (WHO) declaration of a global health emergency concerning monkeypox,

News, SAVIMS Documents, SAVIMS Publications, Vaccines

IMMEDIATE RELEASE: Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox.

| | News, SAVIMS Documents, SAVIMS Publications, Vaccines

Johannesburg, South Africa – 18 August 2024 Click here to download PDF of this press release We are deeply concerned about the recent announcements made by Africa CDC Director General Jean Kaseya on 13 August 2024 and WHO Director-General Tedros Adhanom Ghebreyesus on 14 August 2024. It is important to address these announcements openly to

Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Concerns Over Emergency Monkeypox Vaccine Rollout in Africa

| | Monkeypox, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: SA Vaccine Injury Medco-Legal Study Group – SAVIMS. (2024, August 18). Statement on proposed emergency roll-out of vaccine program in Africa for monkeypox. Johannesburg, South Africa. Retrieved from www.savims.org.za Summary: The SA Vaccine Injury Medco-Legal Study Group (SAVIMS) has expressed significant concerns regarding the proposed emergency rollout of monkeypox vaccines in Africa, as announced

COVID-19, Reference Library, Vaccines

COVID-19 Vaccine Safety

| | COVID-19, Reference Library, Vaccines

Summary The document reviews the safety of COVID-19 vaccines, highlighting adverse events reported post-vaccination. It discusses the monitoring systems in place, such as VAERS and VSD, and the different types of adverse events, including myocarditis and anaphylaxis. The report emphasises the importance of ongoing safety surveillance to identify and mitigate risks, ensuring public confidence in

COVID-19, Reference Library, Vaccines

Minister Kubayi COVID-19 vaccine is voluntary

| | COVID-19, Reference Library, Vaccines

Summary Minister Mmamoloko Kubayi of South Africa reiterated that receiving the COVID-19 vaccine is voluntary. This stance aligns with the government’s approach to respect individual choice while encouraging vaccination to achieve herd immunity. The minister emphasised the importance of vaccination for public health and safety but confirmed that there would be no legal mandate forcing

COVID-19, Reference Library, Vaccines

Language Log Merriam Webster gives vaccine new definition

| | COVID-19, Reference Library, Vaccines

Summary The document discusses the change in the definition of the word “vaccine” by Merriam-Webster. The updated definition now includes not only traditional vaccines, which introduce a weakened or killed pathogen to stimulate immunity, but also new mRNA-based COVID-19 vaccines that work by instructing cells to produce a protein triggering an immune response. This redefinition

COVID-19, Reference Library, Vaccines

Israeli study of breakthrough infections following vaccination

| | COVID-19, Reference Library, Vaccines

Summary The Israeli study examines breakthrough infections in immunocompromised individuals following full vaccination with the Pfizer-BioNTech COVID-19 vaccine. The research reveals that despite full vaccination, immunocompromised patients exhibit a higher incidence of breakthrough infections compared to the general population. The study underscores the need for additional protective measures and potentially booster doses for this vulnerable

Scroll to Top